INTRODUCTION
An initial step in the process of angiogenesis is the degradation of matrix proteins of the basement membrane of endothelial cells (EC). Following matrix remodelling, EC are able to migrate, proliferate and form capillary tubes [1] . The process of matrix degradation by EC is comparable with that seen during leucocyte infiltration and tumour cell invasion [2] . It is generally assumed that plasminogen activators, plasmin and matrix metalloproteinases (MMPs) play an important role in cell migration and angiogenesis [2] [3] [4] . Pepper et al. [4] demonstrated that the formation of capillary tubes from a monolayer of bovine EC in vitro was associated with an increased production of urokinasetype plasminogen activator (u-PA) activity. Expression of u-PA has also been associated with angiogenesis in vivo [5] . In human EC, u-PA synthesis is induced by the inflammatory mediators tumour necrosis factor a (TNFa) and interleukin 1 (IL-1) [6] . Such induction may play a role in angiogenesis, since mononuclear leucocytes are often encountered at sites of angiogenesis [7] , and their products, such as TNFcx, can induce angiogenesis in vivo [8] .
Like the u-PA/plasmin system, MMPs can degrade various matrix proteins. MMP-2 (gelatinase A; 72 kDa type IV collagenase), MMP-3 (stromelysin 1) and MMP-9 (gelatinase B; 92 kDa type IV collagenase) degrade collagen type IV, one of the main components of the basement membrane, and gelatin. Interstitial collagens (types I, II and III), present in the extracellular matrix, are degraded in a two-step process involving an were observed in microvascular endothelial cells. Hence the inflammatory mediator TNFa induces/enhances the production of several matrix metalloproteinases in human endothelial cells. On the other hand, MMP-2 and TIMP-2 were not affected or were affected in a variable way by TNFa and/or phorbol ester, suggesting a dissimilar regulation of these proteins. The cyclic AMP-enhancing agent forskolin affected the production of MMPs in a cell-type-specific way. In human vein endothelial cells it enhanced the PMA-mediated induction of MMP-9, whereas it suppressed this induction in human microvascular endothelial cells and in synovial fibroblasts. On the other hand, forskolin suppressed the PMA-mediated induction of MMP-1 and MMP-3 in synovial fibroblasts, while it enhanced or did not affect this induction in various types of human endothelial cells. These observations may have implications for future pharmacological intervention in angiogenesis.
initial cleavage by MMP-1 (interstitial collagenase), followed by further degradation by MMP-2, MMP-3 or MMP-9 (for review see [9] ). The presence of MMPs has been demonstrated in a number of pathological conditions in which angiogenesis and/or invasive processes play an important role. Increased amounts of MMP-3 have been demonstrated in synovial tissue and synovial fluid of patients with rheumatoid arthritis [10] , and elevated levels of latent and activated MMP-9 were also found in synovial fluids [11, 12] . In tumours an increased expression of MMPs has been correlated to their malignant or metastatic state [13, 14] . The expression of these MMPs is coupled with the potency of cells to invade the extracellular matrix.
Rather little is known about the presence and regulation of the different MMPs in EC. In stimulated bovine and rabbit EC, MMP-l, MMP-2, MMP-3 and MMP-9 have been detected [15, 16] . In human inflamed rheumatoid synovial tissue, including the endothelium of small blood vessels, a considerable amount of MMP-3 was demonstrated [10] , suggesting a functional role of this MMP in the abundant matrix degradation and neovascularization in this tissue.
In this study we have investigated the expression and regulation of the MMP family in various types of human EC. Many of these MMPs and their inhibitors can be induced or 
Cell culture experiments
Human umbilical vein EC (HUVEC) were isolated from human umbilical cord veins by a technique similar to that described by Jaffe et al. [17] . Cells were grown on fibronectin-coated dishes in M 199 supplemented with 100 (v/v) human serum, 10% (v/v) heat-inactivated newborn calf serum, 5 units/ml heparin, 150 ,g/ml endothelial cell growth factor (ECGF; crude extract isolated from bovine hypothalamus) [18] , and penicillin/ streptomycin at 37 'C in a 5 % CO2/95 % air atmosphere. Human femoral vein EC and human foreskin microvascular EC were isolated, cultured and characterized as described previously [19, 20] . Rheumatoid synovial fibroblasts were isolated from freshly dispersed tissue of patients with rheumatoid arthritis, as described [21] . Culture medium was replaced every 2-3 days. Subcultures were obtained by trypsin/EDTA treatment at a split ratio of 1:3. For experiments, confluent cultures of umbilical vein, femoral vein and microvascular EC were used after two to three (n = 6), five to nine (n = 2), and six to ten (n = 3) passages respectively. Synovial fibroblasts were used after four passages (n = 2). Conditioned media were obtained by incubating the cells in 10 cm2 dishes for 8 h, 24 h or 48 h with 1.5 ml of M199 supplemented with 0.1 human serum albumin, 5 units/ml heparin, 150 ,ug/ml ECGF and penicillin/streptomycin to which the appropriate concentration of the test compound was added. The conditioned media were centrifuged for 4 min at 13 000 g in a Microfuge to remove cells and cellular debris, and samples were frozen at -20 'C until use.
Cell extracts were prepared after washing the cells with phosphate-buffered saline, followed by solubilization in 0.50% (w/v) Triton X-100.
RNA analysis
Total cellular RNA was isolated according to the method of Chomczynski and Sacchi [22] . A [28] . The probes were characterized by restriction fragment analysis and/or sequence analysis. The MMP-2 probe (human) was a gift from Dr. K. Tryggvason [29] . The probes for MMP-1 (human) and MMP-3 (rat, full-length cDNA) were kindly supplied by Dr. P. Angel [30] and Dr. L. M. Matrisian [31] respectively.
Substrate gel analysis Gelatinolytic activities of secreted MMPs were analysed by zymography on gelatin-containing polyacrylamide gels as described [32] . Using this technique both active and latent species can be visualized. Samples were made 2 % (w/v) SDS and 10%/O (v/v) glycerol and applied to 10 % (w/v) polyacrylamide gels copolymerized with 0.2 % (w/v) gelatin. After electrophoresis the gels were washed twice for 15 min in 50 mM Tris/HCl, pH 8.0, containing 5 mM CaC12, laM ZnCl2 and 2.5 % (w/v) Triton X-100 to remove the SDS, followed by two washes of 5 min in 50 mM Tris/HCl, pH 8.0, containing 5 mM CaCl2, and incubated overnight in the same buffer at 37 'C. The gels were stained with Coomassie Brilliant Blue R-250.
The presence of MMP-2 and MMP-9 at 72 kDa and 92 kDa respectively was confirmed by Western blotting using polyclonal antibodies for these enzymes. MMP-3 was analysed using 0.2 % (w/v) fibronectin instead of gelatin; fibronectin is a substrate for MMP-3, but not for MMP-1 [33] .
Western blot analysis Cell-conditioned medium was concentrated and the Matrex gel Green A-binding fraction was subjected to SDS/PAGE under reducing conditions, using 100% polyacrylamide gels. Proteins were transferred electrophoretically using a semi-dry blotting device (LKB). Protein A-purified rabbit polyclonal antibodies raised against synthetic peptides representing a part of the Nterminal fragment (latent MMP-2, amino acids 1-10; MMP-3, amino acids [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [34] ) or a part of the catalytic domain (MMP-9), amino acids 422-434 [25] ) were used at a concentration of 10,ug/ml. As a second antibody we used goat anti-rabbit antibody (Nordic, Tilburg, The Netherlands) conjugated to horseradish peroxidase. Detection was carried out using the enhanced chemiluminescent detection method (ECL) (Amersham, Houten,
The Netherlands), according to the manufacturer's instructions.
phoresis in formaldehyde-agarose gels. Following electro-RESULTS MPP expression in non-stimulated human EC Analysis of serum-free conditioned medium of non-stimulated HUVEC and femoral vein EC by zymography showed the presence of gelatinolytic activities at 72 and 55 kDa (Figure 1 , control lanes). These activities were not observed in the presence of EDTA, indicating that they represent metalloproteinases. The main band at 72 kDa corresponds to latent MMP-2. The minor band at 55 kDa corresponds to latent MMP-3 and/or latent MMP-1, which are both able to degrade gelatin in this assay. To discriminate between MMP-1 and MMP-3 we have used zymography with fibronectin instead of gelatin; only MMP-3 is able to degrade fibronectin efficiently [33] . A faint band at 55 kDa was observed on the fibronectin zymogram (results not shown). Western blotting using a polyclonal antibody against MMP-3 also revealed a weak MMP-3 band in non-stimulated EC ( Figure  2, lane 1) . In non-stimulated cells no MMP-9 activity could be detected, despite a higher activity of MMP-9 than of MMP-2 towards gelatin [35] .
Northern blotting analysis using specific cDNA probes for the different MMPs and their inhibitors TIMP-1 and TIMP-2 revealed that the expression of MMP mRNAs corresponds with the presence of enzyme activities, as detected by zymography ( Figure 3 , control lanes). MMP-2 mRNA was clearly detectable in non-stimulated cells, whereas no MMP-3 or MMP-9 mRNAs could be detected. mRNA could easily be detected, whereas the 1.0 kb TIMP-2 mRNA was always present in lower amounts. We subsequently evaluated the production of MMPs in human microvascular EC, because EC from the microvasculature form new capillary sprouts during angiogenesis. Non-stimulated microvascular EC produced predominantly MMP-2 and TIMP-2 mRNAs, with no or relatively small quantities of MMP-1, MMP-3, MMP-9 and TIMP-1 mRNAs (Figure 4b, control (Figure 3a) and had returned to normal values after 24 h (Figures 3b and 3c ). An increase in MMP-3 mRNA was detectable after both 8 (Figure 2) . A weak induction of MMP-9 mRNA was observed in femoral vein EC after 8 and 24 h of incubation with 10 nM PMA. This was paralleled by a clear production of MMP-9 protein as shown by gelatin zymography (Figure la) . Pro- duction of MMP-9 protein was also observed upon stimulation of HUVEC with PMA, although the MMP-9 mRNA could barely be detected (Figures lb and 3c) . The non-tumourpromoting PMA analogue 4a-PDD was unable to induce MMP-9, suggesting that the effect of PMA indeed proceeded via activation of protein kinase C. This was further confirmed by the fact that the inhibitor H-7 (25,M), but not its structurally related homologue HA-1004 (25 ,uM) , completely inhibited the PMA-induced increase in MMP-9 production (results not shown). Although the amounts of MMP-2 protein and mRNA were not visibly affected after exposure to PMA, the appearance in the gelatin zymography of a band of 64 kDa, representing the activated form of latent MMP-2 ( Figure la, lane 4) , was striking. (Figure 3 ). Because the EC were grown before the onset of the experiments in the presence of human serum, which contains MMP-2 and MMP-9, it is possible that these MMPs were of serum origin and have been bound during growth of the cells. To ascertain that the changes in MMP-2 and MMP-9 are not due to an enhanced release of MMPs from the extracellular matrix, Triton X-100 extracts ofcells and matrix were prepared. By gelatin zymography it was established that, after stimulation of the cells by PMA, the amount of MMP-9 and of the activated form of MMP-2 increased both in the medium and in the extract, whereas these MMPs could not be detected in cell extracts of unstimulated cells (results not shown). Therefore the changes in MMP-9 and MMP-2 cannot be caused by a liberation of MMPs from the extracellular matrix.
The production of several PMA-inducible proteins, such as tissue-type plasminogen activator (t-PA) and the urokinase receptor, is further enhanced by the cyclic AMP-enhancing agent forskolin [39, 40] . This phenomenon was also observed for MMP-1, MMP-3, MMP-9 and TIMP-l in vein EC (Figure 3 ). Whereas forskolin alone did not affect the mRNA concentration of any of these proteins, it clearly enhanced (100-800 %) their mRNA levels when it was simultaneously added with PMA (Figure 3 (Figures la and lb) . In contrast, both MMP-9 mRNA and protein production by microvascular EC were consistently suppressed (more than 90 % at the mRNA level) by forskolin in PMA-stimulated cells ( Figure  4 ). It should be noted that the production of MMP proteins did not always reflect their related mRNA levels in the cells. For example, after stimulation of femoral vein EC with PMA and forskolin, MMP-9 protein production hardly increased as compared with stimulation by PMA alone, whereas the mRNA level was increased 8-fold. Obviously, besides induction of transcription, other mechanisms (translational or post-translational) also play a role in the regulation of MMP-9. The 55 kDa band, observed using gelatin zymography, was not suppressed by simultaneous addition of forskolin, but was in fact stimulated. Also at the mRNA level no decrease or even an increase of MMP-l or MMP-3 mRNA (3000% or 1000% respectively) was observed on addition of forskolin in combination with PMA ( Figure 4b ).
MMP expression in EC after stimulation with TNFa or IL-la
Since monocytes are usually encountered in areas of neovascularization, and since the monocyte-derived cytokines TNFa and IL-1 are able to activate EC, we subsequently evaluated the effects of these inflammatory mediators on MMP production by EC. As shown in Figure 3 , TNFa induced MMP-3 mRNA expression in vein EC. Fibronectin zymography (results not shown) and Western blotting (Figure 2 ) further confirmed this increase at the protein level. It is likely that the increase in the gelatinolytic activity at 55 kDa after incubation with TNFa also reflects the increase in (Figures la and lb) . TNFac was not able to induce TIMP-1 mRNA, and no or only a slight increase in TIMP-2 mRNA was observed (Figures 3 and 4) . This suggests that TNFa induces a net proteolytic activity in these cells. IL-la gave similar results as TNFa at the mRNA level. However, no increase in MMP-3 could be detected by Western blotting in ILla-treated femoral vein EC (Figure 2) .
No MMP-9 mRNA could be detected after 8 or 24 h of incubation with TNFa or IL-la (Figure 3) . If, in addition to TNFa, forskolin was added, usually a weak production of MMP-9 protein was observed in vein EC (Figures la and lb) . The corresponding mRNAs could not be detected and were probably below the detection level (Figure 3 ). However, TNFa or IL-la induced a marked increase of MMP-9, at both protein and mRNA levels, when they were incubated simultaneously with PMA (800% increase at mRNA level). Similarly, these inflammatory mediators enhanced the PMA-induced production of MMP-1 and MMP-3 mRNAs [a factor of 1.5-3.5 (Figure 3b) ]. These increases were further enhanced by the simultaneous addition of TNFa, PMA and forskolin.
In microvascular EC similar effects of the inflammatory mediators TNFa and IL-la were found, except that forskolin are constitutively expressed, whereas no MMP-3 and MMP-9 and only a very low amount of MMP-1 mRNA could be detected ( Figure 5 ). Induction of MMP-1, MMP-3 and MMP-9, however, was observed in TNFa-stimulated fibroblasts ( Figure 5 Figure 5 ). However, the regulation by forskolin in fibroblasts clearly differed from that observed in EC. In synovial fibroblasts forskolin decreased the PMA-mediated induction of MMP-1, MMP-9 ( Figure 5 ) and (only detectable after 8 h of stimulation; results not shown), whereas forskolin caused a potentiation of the PMA-induced MMP-1, MMP-3, MMP-9 and TIMP-1 expression in vein EC (Figures 1 and 3 [47] . Our data show that activation of protein kinase C, the generation of cyclic AMP and cellular activation by TNFa, which often acts via the transcription factor NFKB [48] , also interact in the regulation of the expression of various MMPs in human EC. However, in human vein EC the adenylate cyclase activator forskolin enhances the PMA-induced expression of MMP-1, MMP-3 and MMP-9 mRNAs rather than suppressing it, whereas forskolin alone has little effect on them. In human microvascular EC, forskolin enhances the cellular concentrations of MMP-1 and MMP-3 mRNAs after stimulation with PMA, but it causes a suppression of the PMA-mediated MMP-9 induction. These observations contrast with those on synovial fibroblasts, in which forskolin reduces the PMA-stimulated expression of all these MMPs ( [21, 47] ; the present study). They suggest that specific vein and microvascular endothelial factors, which are controlled by cyclic AMP, potentiate the PMA-mediated induction of the cellular mRNA concentrations of MMP-1, MMP-3 and, in vein EC, MMP-9. Similar stimulatory effects of forskolin on EC have been observed in the PMA-induced production of some other EC products, in particular t-PA [39, 49] and the u-PA receptor [40] .
Co-ordinate expression of MMPs and inhibitors in human EC MMP activities are regulated by specific MMP inhibitors, in particular TIMP-1 and TIMP-2. A striking phenomenon in the regulation of MMPs and TIMPs is the more or less similar regulation within one group of MMPs (MMP-1, MMP-3 and MMP-9) and TIMP-1, and within a second group (MMP-2 and TIMP-2). Among others, Murphy et al. [50] and Colige et al. [51] showed a co-ordinated regulation of MMP-1 and its inhibitor TIMP-1. At the protein level it has been described that TIMP-1 can specifically form complexes with the pro-form of MMP-9, and with the activated forms of MMP-1, MMP-3 and MMP-9, whereas TIMP-2 forms complexes with activated and pro-MMP-2 [52] . Our results seem to extend these observations. They demonstrate that, in the regulation of MMP mRNA levels, similar combinations as at the protein level are present: the regulation of MMP-1, MMP-3 and MMP-9 is comparable to the regulation of TIMP-1. It differs from the regulation of MMP-2 and TIMP-2, which are not affected or are affected in a variable way by the different mediators (some variations in MMP-2 and TIMP-2 mRNA expression are observed using different cell cultures). A similar co-ordinated expression of a proteinase and its specific inhibitor has been shown in EC for u-PA and plasminogen activator inhibitor-l [6] . The co-ordinated expression of MMPs and their inhibitors in EC may protect the tissue and act in the fine tuning of local proteolytic activity.
In summary, several MMPs can be induced by the inflammatory mediators TNFa and IL-lIa, or by mediators that activate protein kinase C. The induction of these MMPs may play a role in angiogenesis, since these mediators are present in this process or can induce it. Furthermore, cell specificity was observed in the regulation of MMPs, which may have implications for the pharmacological approach to intervention in the process of angiogenesis which plays a role in many pathological conditions.
